NCT04416958 Pacing to Maintain Physiologic Ventricular Activation
| NCT ID | NCT04416958 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Klinikum-Fuerth |
| Condition | Pacemaker DDD |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2018-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2018-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Right ventricular pacing causes ventricular dyssynchrony and may be associated with impaired outcome. In the last decade, several approaches for more physiological pacing became available and were implemented in the latest guidelines. However, compared to conventional device implantation, cardiac resynchronization, His bundle pacing and left bundle area pacing remain demanding procedures in the individual case. Goal of the single center observational "Pace conduct" study is to evaluate implantation success, safety and outcome of pacing methods that maintain physiologic ventricular activation.
Eligibility Criteria
Inclusion Criteria: * Pacemaker or ICD Implantation aiming to avoid pacing induced ventricular dyssynchrony according to current guidelines * age \>= 18 years Exclusion Criteria: * no informed consent for the procedure given * no follow-up data
Contact & Investigator
Dirk Bastian, MD
PRINCIPAL INVESTIGATOR
Klinikum-Fuerth
Frequently Asked Questions
Who can join the NCT04416958 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pacemaker DDD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04416958 currently recruiting?
Yes, NCT04416958 is actively recruiting participants. Contact the research team at dirk.bastian@klinikum-fuerth.de for enrollment information.
Where is the NCT04416958 trial being conducted?
This trial is being conducted at Fürth, Germany.
Who is sponsoring the NCT04416958 clinical trial?
NCT04416958 is sponsored by Klinikum-Fuerth. The principal investigator is Dirk Bastian, MD at Klinikum-Fuerth. The trial plans to enroll 200 participants.